150 related articles for article (PubMed ID: 29052304)
1. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach.
Naylor PH; Mutchnick MG
J Viral Hepat; 2018 Jan; 25(1):4-9. PubMed ID: 29052304
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Yang YJ; Shen L; Zhang N; Huang P
Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
[TBL] [Abstract][Full Text] [Related]
3. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
[TBL] [Abstract][Full Text] [Related]
4. Thymosin alpha-1 treatment in chronic hepatitis B.
Wu X; Jia J; You H
Expert Opin Biol Ther; 2015; 15 Suppl 1():S129-32. PubMed ID: 25640173
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of sequential antiviral therapy for patients with chronic hepatitis B in China].
Lei CL; Peng XM; Tang XP; Yang Z; Fan HM; Yuan XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):69-72. PubMed ID: 15340532
[TBL] [Abstract][Full Text] [Related]
6. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
Lau GK
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
[TBL] [Abstract][Full Text] [Related]
8. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
9. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.
Shuqun C; Mengchao W; Han C; Feng S; Jiahe Y; Wenming C; Zhengfeng Y; Yuxiang Z; Peijun W
Hepatogastroenterology; 2006; 53(68):249-52. PubMed ID: 16608033
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
Lee HW; Lee JI; Um SH; Ahn SH; Chang HY; Park YK; Hong SP; Moon YM; Han KH
J Gastroenterol Hepatol; 2008 May; 23(5):729-35. PubMed ID: 18410608
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
[TBL] [Abstract][Full Text] [Related]
14. [B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].
Hou J; Wang Z; Sun J
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):574-6. PubMed ID: 11798819
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.
Lim SG; Wai CT; Lee YM; Dan YY; Sutedja DS; Wee A; Suresh S; Wu YJ; Machin D; Lim CC; Fock KM; Koay E; Bowden S; Locarnini S; Ishaque SM
Antivir Ther; 2006; 11(2):245-53. PubMed ID: 16640105
[TBL] [Abstract][Full Text] [Related]
17. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.
Moshier JA; Mutchnick MG; Dosescu J; Holtz TK; Akkary S; Mahakala K; Merline JR; Naylor PH
J Hepatol; 1996 Dec; 25(6):814-20. PubMed ID: 9007707
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
Gao Y; Zhang TY; Yuan Q; Xia NS
Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
[TBL] [Abstract][Full Text] [Related]
19. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
[TBL] [Abstract][Full Text] [Related]
20. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
Liaw YF
J Gastroenterol Hepatol; 2004 Dec; 19 Suppl 6():S73-5. PubMed ID: 15546254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]